carbamates and tg101209

carbamates has been researched along with tg101209 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amaru Calzada, A; Donadoni, L; Finazzi, G; Gatta, R; Golay, J; Introna, M; Lombardi, L; Mantovani, R; Neri, A; Pellicioli, A; Rambaldi, A; Todoerti, K; Tuana, G	1

Other Studies

1 other study(ies) available for carbamates and tg101209

Article	Year
The HDAC inhibitor Givinostat modulates the hematopoietic transcription factors NFE2 and C-MYB in JAK2(V617F) myeloproliferative neoplasm cells. Experimental hematology, 2012, Volume: 40, Issue:8 Topics: Carbamates; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Janus Kinase 2; Mutation; Myeloproliferative Disorders; NF-E2 Transcription Factor, p45 Subunit; Phosphorylation; Proto-Oncogene Proteins c-myb; Pyrimidines; Signal Transduction; Sulfonamides	2012

Article

Year

The HDAC inhibitor Givinostat modulates the hematopoietic transcription factors NFE2 and C-MYB in JAK2(V617F) myeloproliferative neoplasm cells.

Experimental hematology, 2012, Volume: 40, Issue:8

Topics: Carbamates; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Janus Kinase 2; Mutation; Myeloproliferative Disorders; NF-E2 Transcription Factor, p45 Subunit; Phosphorylation; Proto-Oncogene Proteins c-myb; Pyrimidines; Signal Transduction; Sulfonamides

2012